No black box warning on record for Epioxa Cross-Linking
As of the latest FDA labeling reviewed, Epioxa Cross-Linking (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC) does not carry a black box warning. Standard warnings and precautions still apply — see the full Epioxa Cross-Linking medicine page for the complete safety profile.